Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Wendy Yi-Ying Wu"'
Autor:
Adam Rosenbaum, Anna M. Dahlin, Ulrika Andersson, Benny Björkblom, Wendy Yi-Ying Wu, Håkan Hedman, Carl Wibom, Beatrice Melin
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Genome-wide association studies (GWAS) have contributed to our understanding of glioma susceptibility. To date, 25 risk loci for development of any of the glioma subtypes are known. However, GWAS studies reveal little about the molecular pro
Externí odkaz:
https://doaj.org/article/fd0f3a703d9e4e7c89cbe908bd914f26
Autor:
Wendy Yi‐Ying Wu, Florentin Späth, Carl Wibom, Benny Björkblom, Anna M. Dahlin, Beatrice Melin
Publikováno v:
Cancer Medicine, Vol 11, Iss 4, Pp 1016-1025 (2022)
Abstract No strong aetiological factors have been established for glioma aside from genetic mutations and variants, ionising radiation and an inverse relationship with asthmas and allergies. Our aim was to investigate the association between pre‐di
Externí odkaz:
https://doaj.org/article/96b7b1bce85a4b789d8e6dbb8f515c86
Publikováno v:
Experimental Hematology & Oncology, Vol 11, Iss 1, Pp 1-6 (2022)
Abstract Follow-up of low-risk monoclonal gammopathy of undetermined significance (MGUS) is debated as multiple myeloma (MM) progression risk is low. Worse MM outcome was reported for patients followed for low-risk MGUS, possibly due to less optimal
Externí odkaz:
https://doaj.org/article/655bbd0d94964789965cfa81545d3609
Autor:
Wendy Yi-Ying Wu, Sven Törnberg, Klara Miriam Elfström, Xijia Liu, Lennarth Nyström, Håkan Jonsson
Publikováno v:
Breast Cancer Research, Vol 20, Iss 1, Pp 1-11 (2018)
Abstract Background Overdiagnosis, defined as the detection of a cancer that would not become clinically apparent in a woman’s lifetime without screening, has become a growing concern. Similar underlying risk of breast cancer in the screened and co
Externí odkaz:
https://doaj.org/article/3dd9fe032fcd44dd8ed5e2551c72c1ed
Autor:
Wendy Yi‐Ying Wu, Zahra Haider, Xiaoshuang Feng, Alicia K. Heath, Anne Tjønneland, Antonio Agudo, Giovanna Masala, Hilary A. Robbins, José‐María Huerta, Marcela Guevara, Matthias B. Schulze, Miguel Rodriguez‐Barranco, Paolo Vineis, Rosario Tumino, Rudolf Kaaks, Renée T. Fortner, Sabina Sieri, Salvatore Panico, Therese Haugdahl Nøst, Torkjel M. Sandanger, Tonje Braaten, Mattias Johansson, Beatrice Melin, Mikael Johansson
Publikováno v:
Wu, W Y-Y, Haider, Z, Feng, X, Heath, A K, Tjønneland, A, Agudo, A, Masala, G, Robbins, H A, Huerta, M-J, Guevara, M, Schulze, M B, Rodriguez-Barranco, M, Vineis, P, Tumino, R, Kaaks, R, Fortner, R T, Sieri, S, Panico, S, Nost, T H, Sandanger, T M, Braaten, T, Johansson, M, Melin, B & Johansson, M 2023, ' Assessment of the EarlyCDT-Lung test as an early biomarker of lung cancer in ever-smokers : A retrospective nested case-control study in two prospective cohorts ', International Journal of Cancer, vol. 159, no. 9, pp. 2002-2010 . https://doi.org/10.1002/ijc.34340
Int J Cancer
Int J Cancer
The EarlyCDT-Lung test is a blood-based autoantibody assay intended to identify high-risk individuals for low-dose computed tomography lung cancer screening. However, there is a paucity of evidence on the performance of the EarlyCDT-Lung test in ever
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ceb9568acf5d6254c9349d87b0fba834
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-201192
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-201192
Publikováno v:
Neuro-oncology advances. 4(Suppl 2)
Background Understanding the trajectory and development of disease is important and the knowledge can be used to find novel targets for therapy and new diagnostic tools for early diagnosis. Methods Large cohorts from different parts of the world are
Autor:
László Tabár, Peter B. Dean, F. Lee Tucker, Amy Ming-Fang Yen, Tony Hsiu-Hsi Chen, Wendy Yi-Ying Wu, András Vörös
Publikováno v:
European Journal of Radiology. 164:110854
Autor:
Anna Hettinger, Jessica Edlund, Malin Gustafsson, Jenny Lindén, Wendy Yi-Ying Wu, Anna Oudin, Sophia Harlid
Publikováno v:
Cancer Research. 83:4215-4215
Background: Having a family history of breast or ovarian cancer is an important risk factor for premenopausal breast cancer. One reason for this could be that women with an underlying genetic susceptibility are more sensitive to environmental exposur
Autor:
Jessica Lena Edlund, Malin Gustafsson, Jenny Linden, Wendy Yi-Ying Wu, Anna Oudin, Sophia Harlid
Publikováno v:
Cancer Research. 83:4214-4214
Background: Air pollution has been linked to an increased risk of breast cancer, but most previous studies have not considered if the exposure occurred during windows of susceptibility, such as pregnancy. Pregnancy is a period of rapid changes to bot
Autor:
Wendy Yi Ying Wu, Pietro Procopio, Sisse Helle Njor, Jean-Luc Bulliard, Anna Belle Beau, Carolyn Nickson, Elsebeth Lynge
Publikováno v:
Bulliard, J L, Beau, A B, Njor, S, Wu, W Y Y, Procopio, P, Nickson, C & Lynge, E 2021, ' Breast cancer screening and overdiagnosis ', International Journal of Cancer, vol. 149, no. 4, pp. 846-853 . https://doi.org/10.1002/ijc.33602
Overdiagnosis is a harmful consequence of screening which is particularly challenging to estimate. An unbiased setting to measure overdiagnosis in breast cancer screening requires comparative data from a screened and an unscreened cohort for at least